BioAtla, Inc. (BCAB) vs 4D Molecular Therapeutics, Inc. (FDMT)
Detailed comparison between BioAtla, Inc., 4D Molecular Therapeutics, Inc..Total Return (%)
BioAtla, Inc. (BCAB)4D Molecular Therapeutics, Inc. (FDMT)
Which stock do you think will perform better?
BioAtla, Inc.
BCAB
4D Molecular Therapeutics, Inc.
FDMT
| Metric | BioAtla, Inc. (BCAB) | 4D Molecular Therapeutics, Inc. (FDMT) |
|---|---|---|
| Current Price | $0.36 | $4.26 |
| Change | -0.01 (-2.99%) | -0.10 (-2.30%) |
| Market Cap | $0.02B | $0.20B |
| Trailing P/E | 0.00 | 0.00 |
| Forward P/E | -0.24 | -1.29 |
| Dividend Yield | 0.00% | 0.00% |
| 52-Week High | $2.52 | $28.93 |
| 52-Week Low | $0.24 | $2.23 |
| Beta | 0.00 | 0.00 |
| Earnings Per Share | $-1.22 | $-3.18 |
Processing data. Please try again later.
Average Return
| Symbol | 1 Month | Year-to-date | 1 Year | 5 Years | 10 Years | Max |
|---|---|---|---|---|---|---|
| BCAB | -10.35% | -28.81% | -78.85% | -98.84% | -98.84% | -98.84% |
| FDMT | 3.15% | -8.78% | -70.42% | -89.48% | -89.48% | -89.48% |